At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

To support the new partnership and future growth, Divi's Laboratories plans to invest between ₹650 crore and ₹700 crore in ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, March 12, 2025 /EINPresswire ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

(Purdue University file photo) Download Photo WEST LAFAYETTE, Ind., and KNOXVILLE, Tenn. – The Chao Center for Industrial Pharmacy and Contract Manufacturing will increase its pharmaceutical ...

s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing contract ... deal covers supply of both the active pharmaceutical ingredient, or API, and ...

for partnership in contract pharmaceutical manufacturing. The agreement will allow Lotte Biologics to use Asimov's next-generation cell line development platform technology to provide "end-to-end ...

with an undisclosed U.S. pharmaceutical firm to provide contract manufacturing organization (CMO) services. The deal represents 3.01 percent of the U.S. company’s annual revenue last year ...

SEATTLE--(BUSINESS WIRE)--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization ... small molecule active pharmaceutical ingredients, and agrochemicals.

Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good news.